Researchers connect severity of 'kissing disease' to T-cell population

December 5, 2017, American Society for Microbiology

Acute infectious mononucleosis (AIM), also known as mono or the "kissing disease," is caused by the Epstein-Barr Virus (EBV). In a paper published this week in mBio, researchers connect the onset and severity of mono to T-cells that react to both EBV and the influenza A virus, which causes the flu. The study represents one of the first reported links between how a person's immune system responds to infection and receptors on T-cells, which instigate the immune response.

A person's immune system remembers the -causing microbes it encounters over a lifetime. Each time a person is infected with some pathogen - like the influenza virus - T cells retain information. "You develop every time you have any infection," says pathologist and study leader Liisa Selin at the University of Massachusetts Medical School in Worcester, Mass. As a result, individuals develop cells with a heterogeneous mix of that evolves during their lifetime.

"Everybody has different memory cells with different T on them," says Selin, "even genetically identical twins." A person's repertoire of receptors, she says, "determines whether you get infectious mono or not."

Not everyone does. According to the Centers for Disease Control and Prevention, almost everyone - 95 percent of the world population - is infected with EBV by the time they reach 30. However, children infected with the virus rarely suffer the debilitating symptoms of mono, like fatigue, fever, and sore throat. Even some adults barely notice the infection. That may be because of their immune history: They don't have the specific receptors in those cross-reactive memory T cells that trigger a severe , Selin says.

She and her colleagues studied blood samples collected over a decade from college students: 32 diagnosed with mono, separated into two groups by severity of the disease, and 17 healthy controls who had tested positive for EBV. People with severe cases of mono had 25 times more T-cells that reacted to both Influenza A and EBV, per volume of blood, than the healthy controls. Similarly, people with mild cases had 10 times more of the cross-reactive T-cells than the EBV+ participants.

EBV is a tricky virus that can hide quietly for years - or even decades - in the tonsils, says Selin. The new work may help explain how a person's history of disease exposure can influence their susceptibility to disease.The findings suggest, for example, that a previous flu infection may make mono worse.

"If you have a lot of these flu memory T-cells in your tonsils and you get EBV, instead of silently hanging around, it activates those memory cells," says Selin. She hypothesizes that if young adults can avoid the flu, as by getting vaccinated, they might have fewer memory T-cells that were cross-reactive to influenza. As a result, they may be less likely to develop severe mono after EBV infection.

The findings reach beyond the kissing disease: EBV is associated with many autoimmune diseases, though the reasons why remain a mystery. Having infectious mono, for example, may increase a person's risk of developing multiple sclerosis.

The study adds to a growing body of research aimed at understanding the connections among T cell receptors, infectious disease outcomes and autoimmunity. A clear understanding this relationship, Selin says, may enable researchers to identify T- with specific receptors that can worsen the symptoms and pathology during an and may even sometimes lead to autoimmunity.

Explore further: Virus that causes mono may increase risk of MS for multiple races

Related Stories

Virus that causes mono may increase risk of MS for multiple races

August 30, 2017
Like whites, Hispanic and black people who have had mononucleosis, commonly known as mono, which is caused by Epstein-Barr virus, may have an increased risk of multiple sclerosis (MS), according to a new study published in ...

Researchers apply new immune technologies in search of mono vaccine

May 17, 2017
A research lab at the University of Kansas School of Engineering and School of Pharmacy is analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr ...

Immune system discovery could lead to EBV vaccine to prevent mono, some cancers

October 11, 2013
Development of a vaccine against Epstein-Barr virus (EBV) has taken a step forward with the Canadian discovery of how EBV infection evades detection by the immune system.

College students bringing home mononucleosis

December 6, 2013
One of the hallmarks of heading home for winter break is the enormous amount of laundry college students bring home as a present for mom and dad. But the dirty socks might not be the only unwelcome guest they transport home. ...

Dendritic cells 'divide and conquer' to elude viral infection while promoting immunity

July 7, 2017
A research team led by Jackson Laboratory (JAX) Professor Karolina Palucka, M.D., Ph.D., in collaboration with a research team at Institut Curie in France led by Dr. Nicolas Manel, have addressed a long-standing puzzle of ...

Young killer cells protect against infectious mononucleosis

December 19, 2013
More than 90 percent of all adults are carriers of the oncogenic Epstein-Barr Virus (EBV). Primary infection with this herpes virus as a young child is generally not linked to any symptoms, and usually offers life-long protection ...

Recommended for you

Dialysis patients at risk of progressive brain injury

December 10, 2018
Kidney dialysis can cause short-term 'cerebral stunning' and may be associated with progressive brain injury in those who receive the treatment for many years. For many patients with kidney failure awaiting a kidney transplant ...

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

Infectivity of different HIV-1 strains may depend on which cell receptors they target

December 6, 2018
Distinct HIV-1 strains may differ in the nature of the CCR5 molecules to which they bind, affecting which cells they can infect and their ability to enter cells, according to a study published December 6 in the open-access ...

Protecting cell powerhouse paves way to better treatment of acute kidney injury

December 6, 2018
For the first time, scientists have described the body's natural mechanism for temporarily protecting the powerhouses of kidney cells when injury or disease means they aren't getting enough blood or oxygen.

New study uncovers why Rift Valley fever is catastrophic to developing fetuses

December 5, 2018
Like Zika, infection with Rift Valley fever virus can go unnoticed during pregnancy, all the while doing irreparable—often lethal—harm to the fetus. The results of a new study, led by researchers at the University of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.